Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Pancreatic Cancer – Need to Know- A diagnosis of pancreatic cancer can be overwhelming. It’s one of the most challenging cancers to detect early and treat effectively, and understanding the disease, its risk factors, symptoms, diagnosis, and treatment options is essential for making confident decisions and improving outcomes.
Pancreatic cancer often doesn’t cause symptoms until it has progressed, which makes awareness and education especially powerful for patients and caregivers alike. In this article, we’ll break down key facts you should know, based on current medical knowledge.
This post explains the essentials of pancreatic cancer and highlights evidence-based integrative therapies that may improve treatment tolerance, immune function, and survivorship.
Be sure to watch each of the videos about:
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I live in complete remission from my incurable blood cancer. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
Scroll down the page and post a question or a comment if there’s anything you’d like to know about lung cancer.
Good luck,
Pancreatic cancer begins when cells in the pancreas — a small organ located deep in the abdomen behind the stomach — begin to grow uncontrollably. The pancreas has two primary roles:
Most pancreatic cancers start in the cells lining the ducts of the pancreas (called pancreatic ductal adenocarcinoma). Because the pancreas is tucked away and tumors often grow silently, this cancer is frequently diagnosed at an advanced stage.
Although anyone can develop pancreatic cancer, several risk factors are associated with a higher likelihood of developing the disease:
Knowing your personal risk can help guide conversations with your healthcare team and may influence how closely you’re monitored.
Pancreatic cancer often causes no symptoms in its early stages. When symptoms do appear, they tend to be vague and easily confused with other conditions. Common signs include:
If you notice persistent symptoms, don’t ignore them — especially if they don’t go away or worsen over time.
Diagnosing pancreatic cancer typically involves a combination of tools:
Once the diagnosis is confirmed, staging helps determine how far the cancer has spread — from localized (stage 0 or I) to more advanced (stage IV) disease.
Treatment depends heavily on the stage of the cancer, overall health, and patient preferences. Common approaches include:
Chemotherapy uses drugs to attack cancer cells and may be given before (neoadjuvant) or after (adjuvant) surgery — or as a primary therapy when surgery isn’t feasible.
Uses high-energy beams to kill cancer cells or shrink tumors. It may be used in combination with chemotherapy.
Some patients may benefit from therapies aimed specifically at cancer cells or that help the immune system respond to the cancer.
Treatment may also be combined in different sequences based on the individual case.
Pancreatic cancer is notoriously difficult to detect early because symptoms often don’t appear until the disease has progressed, and there are no routine screening tests for the general population. This contributes to its lower overall survival rates compared with many other cancers.
However, researchers are making strides in early detection technologies. For example, novel blood tests being developed — such as the PAC-MANN protease-based assay — aim to detect the disease earlier with simple blood samples, which could dramatically improve outcomes if widely implemented.
Integrative oncology combines conventional treatments (surgery, chemotherapy, radiation, immunotherapy) with supportive, evidence-based complementary therapies to improve quality of life and manage symptoms, reduce treatment side effects, and address psychosocial needs. It does not replace standard cancer therapy.
These approaches have some clinical or research support for symptom relief, quality of life (QoL), or reducing side effects:
Nutrition counseling / tailored diet plans — helps maintain weight and reduce malnutrition, common in pancreatic cancer.
Digestive enzyme therapy — often used to address malabsorption and weight loss, which can improve energy and QoL.
Microbiome support/probiotics — emerging evidence suggests they may modulate treatment tolerance and GI symptoms, but research is still preliminary.
Note: Dietary supplements should be discussed with an oncologist because some can interact with chemotherapy.
Evidence shows benefits in symptom control and psychological health:
Some agents have been studied in combination with conventional therapy — not as replacements — and most evidence is early, mixed, or preliminary:
Important: Most of these are not proven to improve survival and are under research — use only in clinical trial settings or with oncology guidance.
Supported for symptom/QoL improvement
Adjuncts under study (no survival proof)
High-dose intravenous (IV) vitamin C is one of the most researched integrative therapies in oncology.
Unlike oral vitamin C, IV administration produces pharmacologic blood concentrations capable of generating hydrogen peroxide selectively within tumor environments. This mechanism may damage cancer cells while sparing healthy tissue.
Preclinical and clinical research suggests IV vitamin C may provide several benefits:
Laboratory and animal studies demonstrate that high-dose vitamin C may enhance tumor sensitivity to chemotherapy agents commonly used in lung cancer.
A study published in Cancer Cell showed that pharmacologic vitamin C levels selectively killed cancer cells by increasing oxidative stress in tumors.
Clinical trials evaluating IV vitamin C in advanced cancers have demonstrated reductions in fatigue, nausea, pain, and appetite loss compared with chemotherapy alone.
A phase I clinical trial found that IV vitamin C combined with chemotherapy was safe and associated with improved quality-of-life scores.
Early research suggests vitamin C may improve radiation sensitivity in tumor cells while protecting normal tissue from oxidative damage.
IV vitamin C is generally well tolerated but requires screening for:
Patients should only receive IV vitamin C under physician supervision.
What is Prehabilitation?
Prehabilitation evidence has grown across several areas of oncology care delivery, demonstrating that a multi-modal rehabilitative intervention, delivered prior to oncology-directed therapies, leads to better functional outcomes and improves important endpoints associated with surgery and cancer treatment…
✅ Always discuss any integrative therapy with your oncology team — some supplements can interact with chemotherapy or radiation.
✅ Use integrative therapies as supportive care, not replacements for surgery, chemotherapy, radiation, or immunotherapy.
✅ Participation in clinical trials is often the best way to access promising integrative agents safely.
Pancreatic Cancer – Need to Know Pancreatic Cancer – Need to Know Pancreatic Cancer – Need to Know Pancreatic Cancer – Need to Know